Literature DB >> 7834753

Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family.

F Weih1, D Carrasco, S K Durham, D S Barton, C A Rizzo, R P Ryseck, S A Lira, R Bravo.   

Abstract

RelB, a member of the NF-kappa B/Rel family of transcription factors, has been implicated in the constitutive expression of kappa B-regulated genes in lymphoid tissues. We have generated mice carrying a germline mutation of the relB gene, resulting in the absence of RelB protein and a dramatic reduction of constitutive kappa B-binding activity in thymus and spleen. Mice homozygous for the disrupted relB locus had phenotypic abnormalities including multifocal, mixed inflammatory cell infiltration in several organs, myeloid hyperplasia, splenomegaly due to extramedullary hematopoiesis, and a reduced population of thymic dendritic cells. RelB-deficient animals also had an impaired cellular immunity, as observed in contact sensitivity experiments. Thus, RelB plays a decisive role in the hematopoietic system, and its absence cannot be functionally compensated by any other member of the NF-kappa B/Rel family.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7834753     DOI: 10.1016/0092-8674(95)90416-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  254 in total

Review 1.  Lipopolysaccharide induction of gene expression in human monocytic cells.

Authors:  N Mackman
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  NF-kappaB and apoptosis in mammary epithelial cells.

Authors:  R W Clarkson; C J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

3.  Expression of the RelB transcription factor correlates with the activation of human dendritic cells.

Authors:  G J Clark; S Gunningham; A Troy; S Vuckovic; D N Hart
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

4.  RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function.

Authors:  B J O'Sullivan; K P MacDonald; A R Pettit; R Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  T-cell tolerance: central and peripheral.

Authors:  Yan Xing; Kristin A Hogquist
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

6.  Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium.

Authors:  D M Brantley; C L Chen; R S Muraoka; P B Bushdid; J L Bradberry; F Kittrell; D Medina; L M Matrisian; L D Kerr; F E Yull
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

7.  DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity.

Authors:  Sinyi Kong; Muthusamy Thiruppathi; Quan Qiu; Zhenghong Lin; Hongxin Dong; Eduardo N Chini; Bellur S Prabhakar; Deyu Fang
Journal:  J Immunol       Date:  2014-10-31       Impact factor: 5.422

8.  TRAF3 enforces the requirement for T cell cross-talk in thymic medullary epithelial development.

Authors:  S Rhiannon Jenkinson; Joy A Williams; Hyein Jeon; Jingjing Zhang; Takeshi Nitta; Izumi Ohigashi; Michael Kruhlak; Saulius Zuklys; Susan Sharrow; Anthony Adams; Larry Granger; Yongwon Choi; Ulrich Siebenlist; Gail A Bishop; Georg A Hollander; Yousuke Takahama; Richard J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

9.  Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation.

Authors:  Brendan A Hilliard; Nicola Mason; Lingyun Xu; Jing Sun; Salah-Eddine Lamhamedi-Cherradi; Hsiou-Chi Liou; Christopher Hunter; Youhai H Chen
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury.

Authors:  Fiona Oakley; Jelena Mann; Sarah Nailard; David E Smart; Narendra Mungalsingh; Christothea Constandinou; Shakir Ali; Susan J Wilson; Harry Millward-Sadler; John P Iredale; Derek A Mann
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.